Intravitreal injection of anti-miRs against miR-142-3p reduces angiogenesis and microglia activation in a mouse model of laser-induced choroidal neovascularization

Aging (Albany NY). 2021 May 5;13(9):12359-12377. doi: 10.18632/aging.203035. Epub 2021 May 5.

Abstract

Age-related macular degeneration (AMD) is a worldwide leading cause of blindness affecting individuals over 50 years old. The most aggressive form, wet AMD, is characterized by choroidal neovascularization (CNV) and inflammation involving microglia recruitment. By using a laser-induced CNV mouse model, we provide evidence for a key role played by miR-142-3p during CNV formation. MiR-142-3p was overexpressed in murine CNV lesions and its pharmacological inhibition decreased vascular and microglia densities by 46% and 30%, respectively. Consistently, miR-142-3p overexpression with mimics resulted in an increase of 136% and 126% of blood vessels and microglia recruitment. Interestingly, miR-142-3p expression was linked to the activation state of mouse microglia cells as determined by morphological analysis (cell solidity) through a computational method. In vitro, miR-142-3p overexpression in human microglia cells (HMC3) modulated microglia activation, as shown by CD68 levels. Interestingly, miR142-3p modulation also regulated the production of VEGF-A, the main pro-angiogenic factor. Together, these data strongly support the unprecedented importance of miR-142-3p-dependent vascular-inflammation axis during CNV progression, through microglia activation.

Keywords: age-related macular degeneration; angiogenesis; inflammation; miR-142-3p; microglia.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Choroidal Neovascularization / drug therapy*
  • Choroidal Neovascularization / genetics*
  • Choroidal Neovascularization / pathology
  • Disease Models, Animal
  • Intravitreal Injections / methods
  • Lasers*
  • Macrophage Activation / genetics
  • Macular Degeneration / drug therapy
  • Macular Degeneration / metabolism
  • Mice
  • MicroRNAs / pharmacology*
  • Microglia / drug effects
  • Microglia / metabolism

Substances

  • MIRN142 microRNA, human
  • MicroRNAs